Risk Management EU MDR Perspective Risk management is understood as a continuous iterative process throughout the entire lifecycle of a device, requiring.

Slides:



Advertisements
Similar presentations
Comparison GHTF/SG5/N5:2012 vs. MEDDEV 2.7/3:2010
Advertisements

[Organisation’s Title] Environmental Management System
Center for Clinical Research - Clinical Trials Center (CTC) Clinical Research and Clinical Trials in Switzerland Jürg Lustenberger, PhD Dipl. Pharm. Med.
Laboratory Accreditation – An Assessors Perspective Dr Jonathan berg City Hospital, Birmingham.
© Safeguarding public health Implementing Medical Device Regulation and Maintaining Patient Safety Name Nicola Lennard Date October 2011.
Page 1 R Risk-Driven and Iterative Development. Page 2 R Copyright © 1997 by Rational Software Corporation What the Iterative Life Cycle Is Not It is.
ISO Environmental Management System JVC Registration Overview.
Slide 1 of 37 Robert Packard, Consultant Medical Device Directive (MDD) 93/42/EEC as modified by 2007/47/EC.
Regulatory requirements and benefits converting to Continued Process Verification.
Standard 5: Patient Identification and Procedure Matching Nicola Dunbar, Accrediting Agencies Surveyor Workshop, 10 July 2012.
Picture 1 model: ICT lifecycle in a company 1. business needs & business strategy 2. ICT strategy - ICT assessment - ICT strategic plan - ICT implementation/tactical.
Designing Classes OO Software Design and Construction Computer Science Dept Va Tech January 2002 ©2002 McQuain WD & Keller BJ 1 Designing the Classes Once.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
UNIT-II Chapter : Software Quality Assurance(SQA)
Marketing Research  Def. - Formal communication link with the environment to provide accurate and useful information for better decision making.  Systematic.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
Basics of OHSAS Occupational Health & Safety Management System
Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.
Supplier Overview of Johnson & Johnson MD&D Supplier Quality Standard Operating Procedures (SOPs) Supplier Process Control.
Product Development Chapter 6. Definitions needed: Verification: The process of evaluating compliance to regulations, standards, or specifications.
BPA 1 Verification in the Development of Medical Device Software Per IEC Tim Stein, Ph.D. CEO and President of Business Performance Associates, Inc.
Medical Call Center Project Name Company Name Presenter Name.
ISO 9001:2008 to ISO 9001:2015 Summary of Changes
Software Engineering MCS-2 Lecture # 6
ISO 14001:2015 Explaining the Key Changes
OHRP Guidance and Policy Development Process Secretary’s Advisory Committee on Human Research Protections Meeting October 27, 2008 Irene Stith-Coleman,
DISCOVERY HEALTH COMMENTS ON THE MEDICINES AND RELATED SUBSTANCES BILL August 2008.
PRJ566 Project Planning & Management Software Architecture.
A Guide for Management. Overview Benefits of entity-level controls Nature of entity-level controls Types of entity-level controls, control objectives,
The Business Plan: Creating and Starting the Venture
Employee Orientation to ISO Sygnetics, Inc. is committed to quality. ‘Quality’ is the ability to consistently produce a product or service that.
European Patients’ Academy on Therapeutic Innovation Aspects of pharmacovigilance: Periodic Safety Update Reports (PSURs)
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 6 CH 5 ISO MANAGEMENT RESPONSIBILITY Philippe Bauwin Medical.
Software Engineering Process - II 7.1 Unit 7: Quality Management Software Engineering Process - II.
Risk Assessment Techniques
Quarterly Geo/SIG Coordinator Webinar June 25, 2014.
KEVIN BEDAL LISA CARLIN MATT CARROLL ERIN NICHOLS Product Safety & Failure Analysis.
rSDV offers the best alternative option to altogether reduce onsite monitoring activities, how to maintain subject privacy in the process of collecting source documents and what 21 CFR Part 11 requires, strategies for remote review of source documents at
Clusters working group COM/CAMD New Regulations
Industry Implementation Priorities & Challenges COM/CAMD Stakeholders meeting on the new MD and IVD Regulations 9 March, 2017 John Brennan Director.
FDA's Two New Draft Guidance on Software and Device
Analysis of Current Maturity Models and Standards
Growing need of Clinical Data, PMCF & Registries for Devices Post Market Clinical Follow Up (PMCF) studies are a critical component of the clinical evidence.
Balancing Pre and Postmarket Requirements Different Scenarios
Become and Entrepreneur
Fundamentals of ISO.
9/16/2018 The ACT Government’s commitment to Performance and Accountability – the role of Evaluation Presentation to the Canberra Evaluation Forum Thursday,
MakroCare is organizing the webinar on Importance & Requirements of Clinical Evaluation for CER. This webinar is planned to focus on ensuring that clinical data are evaluated in a systematic and objective way, that the benefit/risk profile is acceptable a
TSMO Program Plan Development
MakroCare is organizing the webinar on Device Registries as PMCF tools. This webinar will provide an overview of PMCF requirements, outline elements of a well-designed registry and offer advice about known, potential pitfalls.
Medical Device PMS & PMCF: Challenges & Opportunities The new 2017/745/EU Medical Device Regulations (MDR-2020) require increased emphasis on Post- Market.
دانشیار دانشکده دندانپزشکی دانشگاه علوم پزشکی شهید صدوقی یزد
Chapter 2 Software Processes
Date (include day of the week)
Systems Development Life Cycle
CIS work programme Ad-hoc activity on Economics
Quality and Regulatory Planning – the way forward?
Safety Management System Implementation
Conformity of Production (COP)
A Practical Introduction to the Clinical Evaluation Report
Medical Device Design and Development
SEC & State/District Initiatives
ISO management systems
TS Training Presented by: Internal Auditor Training.
Evidence standards for device approval: Regulatory perspectives
Aspects of pharmacovigilance: Development Safety Update Report (DSUR)
Essentials of Good Pain Care: A Team-Based Approach
Connecting Planning and Designing
Storage and distribution
Presentation transcript:

Risk Management EU MDR Perspective Risk management is understood as a continuous iterative process throughout the entire lifecycle of a device, requiring regular systematic updating. Though Risk management has been a requirement in MDD also, EU MDR places greater emphasize on this area. EU MDR has provided detailed description on how manufacturers should establish, document, implement and maintain a system for risk management. Risk management system should be carefully aligned with and reflected in the clinical evaluation for the device, including the process of clinical risks that needs to be addressed as part of clinical investigations, clinical evaluation and post-market clinical follow up. Risk Management and clinical evaluation processes should be inter-dependent and should be frequently updated. Considering the importance of risk management with EU MDR, this webinar is designed to focus on the following aspects of risk management in EU-MDR perspective.  Risk management requirement under MDR  Risk-Benefit analysis  Clinical Investigations under MDR  Expectations above and beyond MEDDEV 2.7.1, Rev 4  Conformity Assessment Procedures.

About Our Speaker Dr C Lessmann, Ph.D. Risk Management & EU MDR lead, MakroCare Register here: for-risk-management-eu-mdr-perspectivehttps:// for-risk-management-eu-mdr-perspective